Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study
Resource Type
Article
Authors
Dimopoulos, Meletios A ; Moreau, Philippe ; Palumbo, Antonio ; Joshua, Douglas ; Pour, Ludek ; Hájek, Roman ; Facon, Thierry ; Ludwig, Heinz ; Oriol, Albert ; Goldschmidt, Hartmut ; Rosiñol, Laura ; Straub, Jan ; Suvorov, Aleksandr ; Araujo, Carla ; Rimashevskaya, Elena ; Pika, Tomas ; Gaidano, Gianluca ; Weisel, Katja ; Goranova-Marinova, Vesselina ; Schwarer, Anthony ; Minuk, Leonard ; Masszi, Tamás ; Karamanesht, Ievgenii ; Offidani, Massimo ; Hungria, Vania ; Spencer, Andrew ; Orlowski, Robert Z ; Gillenwater, Heidi H ; Mohamed, Nehal ; Feng, Shibao ; Chng, Wee-Joo
Source
In The Lancet Oncology January 2016 17(1):27-38
Subject
Primary Research Articles
Language
ISSN
1470-2045